CAPITOL HILL CONSULTING GROUP for PHRMA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
general healthcare issues related to pharmaceutical and biological products; Federal Food, Drug and Cosmetic Act (21 USC 9); Public Health Service Act (42 USC 6A); Drug Safety: Food and Drug Administration Amendments Act of 2007 (Public Law No. 110-85); FDA Globalization Act (HR 759); Comparative Effectiveness: Comparative Effectiveness Research Act (S.3408); American Recovery and Reinvestment Act of 2008 (Public Law No. 111-5); health care reform; Affordable Health Choices Act, Drug Importation, including The Pharmaceutical Market Access Act (S.80) and The Pharmaceutical Market Access and Drug Safety Act (S.525)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including but not limited to, coverage and reimbursement; Physician Gifts: Physician Payments Sunshine Act (S.301): Medicare Part D: Non-interference; Medicare Prescription Drugs and Modernization Act (Public Law 108-173)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.